Person · CIK 1224091

David L Mahoney

Director at Corcept Therapeutics

Earlier: Adamas Pharmaceuticals, Symantec and Tercica

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$19.4M

Noticed on Form 144$16.5M

Bought on Form 4$1.4M

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Corcept Therapeutics CORT	Common Stock	David L.Mahoney & Winnifred C. Ellis Family Trust	1,203,148	Mar 27, 2015 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	1,135,673	Dec 29, 2016 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	1,133,539	Aug 18, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Common stock	David L. Mahoney & Winnifred C. Ellis Trust Account	1,119,533	May 9, 2014 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	By Trust	1,019,533	Mar 29, 2012 · Filing · EDGAR
Corcept Therapeutics CORT	Common stock	By Foundation	75,000	Jun 3, 2011 · Filing · EDGAR
Corcept Therapeutics CORT	Common Stock	The Black Dog Private Foundation	26,147	Aug 18, 2026 · Filing · EDGAR
Corcept Therapeutics CORT	Stock Option (right to buy) exercise $59.69, expires May 21, 2036, into Common Stock	Directly	12,500	May 21, 2026 · Filing · EDGAR
Adamas Pharmaceuticals	Common Stock	David L. Mahoney + Winnifred C. Ellis 1998 Family Trust	2,628	Apr 15, 2014 · Filing · EDGAR
Symantec	Common Stock	Directly	184,464	May 14, 2019 · Filing · EDGAR
Symantec	Common Stock	Winnifred C Ellis &David L Mahoney TR UA 06/25/1998 David L Mahoney and Winnifred C Ellis Trust	19,527	May 14, 2019 · Filing · EDGAR
Symantec	Common Stock	Winnifred C Ellis & David L Mahoney TR UA 06/25/1998 David L Mahoney and Winnifred C Ellis Trust	16,959	May 14, 2019 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q3 2026	$12.3M	$12.2M	—
Q2 2026	$1.7M	$1.7M	—
Q2 2025	$2M	$2M	—
Q3 2023	$774K	$617K	—
Q3 2017	$375K	Not machine-readable	—
Q4 2016	$281K	Not machine-readable	—
Q3 2015	$194K	Not machine-readable	—
Q1 2015	$182K	Not machine-readable	—
Q4 2014	$304K	Not machine-readable	—
Q2 2014	—	—	$185K
Q4 2012	$984K	Not machine-readable	—
Q2 2011	$365K	Not machine-readable	—
Q2 2010	—	—	$81K
Q4 2009	—	—	$193K
Q1 2009	—	—	$196K
Q1 2008	—	—	$196K
Q1 2007	—	—	$200K
Q1 2006	—	—	$205K
Q2 2005	—	—	$82K
Q4 2004	—	—	$53K

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Corcept Therapeutics CORT · Charles Schwab · 10b5-1 plan adopted May 19, 2026 · 1 notice
Aug 18, 2026	103,606 · ~$12.2M	Aug 18, 2026	Sold as noticed Sold 103,606 in 4 sales, Aug 18 to Aug 18 · $12.3M Form 4	Filing · EDGAR
Corcept Therapeutics CORT · Charles Schwab · No 10b5-1 plan stated · 3 notices
Jun 16, 2026	20,000 · ~$1.7M	Jun 16, 2026	Sold as noticed Sold 20,000 at $84.53 on Jun 17 · $1.7M Form 4	Filing · EDGAR
Aug 14, 2023	10,000 · ~$309K	Aug 14, 2023	Not sold within 90 days	Filing · EDGAR
Aug 14, 2023	10,000 · ~$309K	Aug 14, 2023	Sold as noticed Sold 10,000 at $30.95 on Aug 14 · $309K Form 4	Filing · EDGAR
Corcept Therapeutics CORT · Fidelity Brokerage Services · No 10b5-1 plan stated · 1 notice
May 16, 2025	27,352 · ~$2M	May 16, 2025	Sold as noticed Sold 27,352 in 2 sales, May 16 to May 16 · $2M Form 4	Filing · EDGAR
Sales without a matching Form 144 · 35 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Corcept Therapeutics (CORT): Sold 15,000 at $30.95 on Aug 14, 2023 · $464K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 16,915 at $12.50 on Jul 19, 2017 · $211K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 6,091 at $12.50 on Jul 18, 2017 · $76K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 484 at $12.55 on Jul 13, 2017 · $6K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 6,510 at $12.50 on Jul 12, 2017 · $81K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 30,000 at $9.35 on Nov 11, 2016 · $281K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 33,828 at $5.74 on Jul 8, 2015 · $194K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 14,458 at $5.85 on Mar 20, 2015 · $85K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 16,717 at $5.85 on Mar 20, 2015 · $98K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 12,000 at $25.33 on Dec 15, 2014 · $304K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,600 at $18.83 on Nov 2, 2012 · $30K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,300 at $18.82 on Nov 2, 2012 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,190 at $18.82 on Nov 2, 2012 · $22K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 3,400 at $18.81 on Nov 2, 2012 · $64K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,100 at $18.81 on Nov 2, 2012 · $21K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,400 at $18.81 on Nov 2, 2012 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,700 at $18.80 on Nov 2, 2012 · $32K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 8,900 at $18.80 on Nov 2, 2012 · $167K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 2,500 at $18.80 on Nov 2, 2012 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 4,533 at $18.80 on Nov 2, 2012 · $85K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,000 at $18.79 on Nov 2, 2012 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 700 at $18.79 on Nov 2, 2012 · $13K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 4,536 at $18.79 on Nov 2, 2012 · $85K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 100 at $18.79 on Nov 2, 2012 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 3,100 at $18.79 on Nov 2, 2012 · $58K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 964 at $18.79 on Nov 2, 2012 · $18K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,433 at $18.79 on Nov 2, 2012 · $27K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,514 at $18.78 on Nov 2, 2012 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,200 at $18.78 on Nov 2, 2012 · $23K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 2,900 at $18.78 on Nov 2, 2012 · $54K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 2,300 at $18.78 on Nov 2, 2012 · $43K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 3,900 at $18.77 on Nov 2, 2012 · $73K	Filing · EDGAR
—	—	—	Notice not machine-readable Symantec: Sold 1,100 at $18.76 on Nov 2, 2012 · $21K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 25,000 at $5.03 on Jun 3, 2011 · $126K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics (CORT): Sold 47,481 at $5.04 on Jun 3, 2011 · $239K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Corcept Therapeutics CORT Director · filings 2004 to 2026 · sold $18.1M · bought $1.4M · $16.5M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 18, 2026	Sale under a 10b5-1 plan	−4,984	$117.47	$585K	1,232,161 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Aug 18, 2026	Sale under a 10b5-1 plan	−91,167	$118.24	$10.8M	1,140,994 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Aug 18, 2026	Sale under a 10b5-1 plan	−7,055	$118.88	$839K	1,133,939 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Aug 18, 2026	Sale under a 10b5-1 plan	−400	$119.64	$48K	1,133,539 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jun 17, 2026	Open-market or private sale	−20,000	$84.53	$1.7M	26,147 The Black Dog Private Foundation	Filing · EDGAR
May 21, 2026	Grant or award from the company Stock Option (right to buy)	+12,500			12,500 direct	Filing · EDGAR
Mar 13, 2026	Option or RSU exercised or converted	+30,000	$5.86	$176K	30,000 direct	Filing · EDGAR
Mar 13, 2026	Shares withheld for tax or exercise price	−5,469	$32.15	$176K	24,531 direct	Filing · EDGAR
Mar 13, 2026	Gift	−24,531			0 direct	Filing · EDGAR
Mar 13, 2026	Other acquisition or disposition (see the filing)	+24,531			1,237,145 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Mar 13, 2026	Option or RSU exercised or converted Stock Option (right to buy)	−30,000			0 direct	Filing · EDGAR
Jun 10, 2025	Grant or award from the company Stock option (right to buy)	+15,000			15,000 direct	Filing · EDGAR
May 16, 2025	Option or RSU exercised or converted	+30,000	$6.55	$197K	30,000 direct	Filing · EDGAR
May 16, 2025	Shares withheld for tax or exercise price	−2,648	$74.21	$197K	27,352 direct	Filing · EDGAR
May 16, 2025	Open-market or private sale	−23,829	$74.17	$1.8M	3,523 direct	Filing · EDGAR
May 16, 2025	Open-market or private sale	−3,523	$74.65	$263K	0 direct	Filing · EDGAR
May 16, 2025	Option or RSU exercised or converted Stock option (right to buy)	−30,000			0 direct	Filing · EDGAR
May 17, 2024	Grant or award from the company Stock option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Apr 10, 2024	Option or RSU exercised or converted	+30,000	$1.74	$52K	30,000 direct	Filing · EDGAR
Apr 10, 2024	Shares withheld for tax or exercise price	−2,194	$23.80	$52K	27,806 direct	Filing · EDGAR
Apr 10, 2024	Other acquisition or disposition (see the filing)	−27,806			27,806 direct	Filing · EDGAR
Apr 10, 2024	Other acquisition or disposition (see the filing)	+27,806			1,212,614 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Apr 10, 2024	Option or RSU exercised or converted Stock option (right to buy)	−30,000			0 direct	Filing · EDGAR
Aug 29, 2023	Gift	−17,420			1,204,658 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Aug 29, 2023	Gift	−34,850			1,169,808 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Aug 29, 2023	Gift	+34,850			46,147 The Black Dog Private Foundation	Filing · EDGAR
Aug 14, 2023	Sale under a 10b5-1 plan	−10,000	$30.95	$309K	11,297 The Black Dog Private Foundation	Filing · EDGAR
Aug 14, 2023	Sale under a 10b5-1 plan	−15,000	$30.95	$464K	1,222,078 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
May 19, 2023	Grant or award from the company Stock option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
May 8, 2023	Option or RSU exercised or converted	+30,000	$1.74	$52K	1,239,275 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
May 8, 2023	Shares withheld for tax or exercise price	−2,197	$23.76	$52K	1,237,078 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
May 8, 2023	Option or RSU exercised or converted Stock option (right to buy)	−30,000			0 direct	Filing · EDGAR
Dec 16, 2022	Gift	−21,297			1,209,275 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Dec 13, 2022	Gift	−26,030			1,230,572 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
May 31, 2022	Grant or award from the company Stock option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
May 27, 2022	Option or RSU exercised or converted	+30,000	$4.05	$122K	30,000 direct	Filing · EDGAR
May 27, 2022	Shares withheld for tax or exercise price	−5,786	$21.00	$122K	24,214 direct	Filing · EDGAR
May 27, 2022	Option or RSU exercised or converted Stock Option (Right to Buy)	−30,000			0 direct	Filing · EDGAR
May 26, 2021	Grant or award from the company Stock Option (Right to Buy)	+20,000			20,000 direct	Filing · EDGAR
May 11, 2021	Option or RSU exercised or converted	+30,000	$4.42	$133K	118,984 direct	Filing · EDGAR
May 11, 2021	Shares withheld for tax or exercise price	−6,484	$20.45	$133K	112,500 direct	Filing · EDGAR
May 11, 2021	Gift	−112,500			0 direct	Filing · EDGAR
May 11, 2021	Gift	+112,500			1,232,388 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
May 11, 2021	Option or RSU exercised or converted Stock Option (Right to Buy)	−30,000			0 direct	Filing · EDGAR
May 27, 2020	Grant or award from the company Stock Option (Right to Buy)	+30,000			30,000 direct	Filing · EDGAR
May 22, 2020	Option or RSU exercised or converted	+38,984	$3.47	$135K	88,984 direct	Filing · EDGAR
May 22, 2020	Option or RSU exercised or converted Stock Option (Right to Buy)	−38,984			0 direct	Filing · EDGAR
Jun 18, 2019	Grant or award from the company Stock Option (Right to Buy)	+25,000			25,000 direct	Filing · EDGAR
Jun 3, 2019	Option or RSU exercised or converted	+50,000	$0.96	$48K	50,000 direct	Filing · EDGAR
Jun 3, 2019	Option or RSU exercised or converted Stock Option (Right to Buy)	−50,000			0 direct	Filing · EDGAR
Aug 20, 2018	Grant or award from the company Stock Option (Right to Buy)	+25,000			25,000 direct	Filing · EDGAR
Nov 16, 2017	Gift	−15,785			1,119,888 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 19, 2017	Option or RSU exercised or converted	+16,915	$2.23	$38K	1,152,588 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 19, 2017	Sale under a 10b5-1 plan	−16,915	$12.50	$211K	1,135,673 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 19, 2017	Option or RSU exercised or converted Stock Option (Right to Buy)	−16,915			0 direct	Filing · EDGAR
Jul 18, 2017	Option or RSU exercised or converted	+6,091	$2.23	$14K	1,141,764 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 18, 2017	Sale under a 10b5-1 plan	−6,091	$12.50	$76K	1,135,673 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 18, 2017	Option or RSU exercised or converted Stock Option (Right to Buy)	−6,091			16,915 direct	Filing · EDGAR
Jul 13, 2017	Option or RSU exercised or converted	+484	$2.23	$1K	1,136,157 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Jul 13, 2017	Sale under a 10b5-1 plan	−484	$12.55	$6K	1,135,673 Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR

53 earlier transactions are in the filing list below.

Adamas Pharmaceuticals Director · filings 2014 to 2021

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 24, 2021	Tendered in a change of control	−5,000			0 direct	Filing · EDGAR
Nov 24, 2021	Tendered in a change of control	−112,781			0 David L. Mahoney & Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Nov 24, 2021	Returned to the company Stock Option (Right to Buy)	−10,000			0 direct	Filing · EDGAR
Nov 24, 2021	Returned to the company Stock Option (Right to Buy)	−40,000			0 direct	Filing · EDGAR
Nov 24, 2021	Returned to the company Stock Option (Right to Buy)	−10,000			0 direct	Filing · EDGAR
Nov 24, 2021	Returned to the company Stock Option (Right to Buy)	−10,000			0 direct	Filing · EDGAR
Jun 2, 2021	Grant or award from the company	+5,000			115,153 direct	Filing · EDGAR
Jun 2, 2021	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Mar 12, 2021	Option or RSU exercised or converted	+48,000	$0.67	$32K	110,153 direct	Filing · EDGAR
Mar 12, 2021	Option or RSU exercised or converted Stock Option (Right to Buy)	−48,000			0 direct	Filing · EDGAR
Jun 3, 2020	Grant or award from the company	+5,000			62,153 direct	Filing · EDGAR
Jun 3, 2020	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Sep 17, 2019	Option or RSU exercised or converted	+33,332	$1.76	$58K	57,153 direct	Filing · EDGAR
Sep 17, 2019	Option or RSU exercised or converted Stock Option (Right to Buy)	−33,332			0 direct	Filing · EDGAR
Sep 11, 2019	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR
Jun 5, 2019	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 6, 2018	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Nov 29, 2017	Grant or award from the company Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 1, 2017	Grant or award from the company Stock Option (Right to Buy)	+15,000			15,000 direct	Filing · EDGAR
Jun 3, 2016	Grant or award from the company Stock Option (Right to Buy)	+15,000			15,000 direct	Filing · EDGAR
May 14, 2015	Grant or award from the company Stock Option (Right to Buy)	+19,000			19,000 direct	Filing · EDGAR
Apr 15, 2014	Derivative converted	+13,147			23,821 direct	Filing · EDGAR
Apr 15, 2014	Derivative converted	+2,628			2,628 David L. Mahoney + Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Apr 15, 2014	Derivative converted Series AA Convertible Preferred Stock	−13,144			0 direct	Filing · EDGAR
Apr 15, 2014	Derivative converted Series AA Convertible Preferred Stock	−2,628			0 David L. Mahoney + Winnifred C. Ellis 1998 Family Trust	Filing · EDGAR
Apr 15, 2014	Derivative converted Series AA-1 Convertible Preferred Stock	−3			0 direct	Filing · EDGAR

Symantec Director · filings 2003 to 2019 · sold $1.3M

Date	Transaction	Shares	Price	Value	Held after	Source
May 14, 2019	Grant or award from the company	+14,124			16,959 Winnifred C Ellis &David L Mahoney TR UA 06/25/1998 David L Mahoney and Winnifred C Ellis Trust	Filing · EDGAR
May 14, 2019	Grant or award from the company	+2,568	$19.47	$50K	19,527 Winnifred C Ellis &David L Mahoney TR UA 06/25/1998 David L Mahoney and Winnifred C Ellis Trust	Filing · EDGAR
May 17, 2018	Grant or award from the company	+12,320			184,464 direct	Filing · EDGAR
May 15, 2017	Grant or award from the company	+8,593			174,979 direct	Filing · EDGAR
May 17, 2016	Grant or award from the company	+16,233			163,435 direct	Filing · EDGAR
May 17, 2016	Grant or award from the company	+2,951	$16.94	$50K	166,386 direct	Filing · EDGAR
May 19, 2015	Grant or award from the company	+9,362			147,202 direct	Filing · EDGAR
Dec 15, 2014	Option or RSU exercised or converted	+12,000	$21.93	$263K	149,840 direct	Filing · EDGAR
Dec 15, 2014	Sale under a 10b5-1 plan	−12,000	$25.33	$304K	137,840 direct	Filing · EDGAR
Dec 15, 2014	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−12,000			0 direct	Filing · EDGAR
May 13, 2014	Grant or award from the company	+11,058			137,840 direct	Filing · EDGAR
May 10, 2013	Grant or award from the company	+9,650			126,782 direct	Filing · EDGAR
Nov 2, 2012	Option or RSU exercised or converted	+70,000	$9.91	$694K	169,502 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,100	$18.76	$21K	168,402 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−3,900	$18.77	$73K	164,502 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−2,300	$18.78	$43K	162,202 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−2,900	$18.78	$54K	159,302 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,200	$18.78	$23K	158,102 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,514	$18.78	$28K	156,588 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,433	$18.79	$27K	155,155 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−964	$18.79	$18K	154,191 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−3,100	$18.79	$58K	151,091 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−100	$18.79	$2K	150,991 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−4,536	$18.79	$85K	146,455 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−700	$18.79	$13K	145,755 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,000	$18.79	$19K	144,755 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−4,533	$18.80	$85K	140,222 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−2,500	$18.80	$47K	137,722 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−8,900	$18.80	$167K	128,822 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,700	$18.80	$32K	127,122 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,400	$18.81	$26K	125,722 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,100	$18.81	$21K	124,622 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−3,400	$18.81	$64K	121,222 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,190	$18.82	$22K	120,032 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,300	$18.82	$24K	118,732 direct	Filing · EDGAR
Nov 2, 2012	Open-market or private sale	−1,600	$18.83	$30K	117,132 direct	Filing · EDGAR
Nov 2, 2012	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−70,000			0 direct	Filing · EDGAR
May 7, 2012	Grant or award from the company	+12,547			99,502 direct	Filing · EDGAR
May 16, 2011	Grant or award from the company	+10,152			86,955 direct	Filing · EDGAR
May 10, 2010	Grant or award from the company	+12,338			76,803 direct	Filing · EDGAR
May 11, 2009	Grant or award from the company	+11,749			64,465 direct	Filing · EDGAR
Apr 30, 2008	Grant or award from the company	+10,452			52,716 direct	Filing · EDGAR
Apr 29, 2008	Grant or award from the company	+1,433			42,264 direct	Filing · EDGAR
May 2, 2007	Grant or award from the company	+9,906			40,831 direct	Filing · EDGAR
May 1, 2007	Grant or award from the company	+1,402			30,925 direct	Filing · EDGAR
Sep 14, 2006	Grant or award from the company	+9,113			29,523 direct	Filing · EDGAR
Apr 25, 2006	Grant or award from the company	+1,558	$16.04	$25K	20,410 direct	Filing · EDGAR
Sep 19, 2005	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Aug 26, 2005	Option or RSU exercised or converted	+10,000	$9.91	$99K	18,852 direct	Filing · EDGAR
Aug 26, 2005	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			70,000 direct	Filing · EDGAR
Apr 25, 2005	Grant or award from the company	+1,310	$19.07	$25K	8,852 direct	Filing · EDGAR
Sep 17, 2004	Grant or award from the company EMPLOYEE STOCK OPTION GRANT	+12,000	$51.01	$612K	12,000 direct	Filing · EDGAR
Apr 27, 2004	Grant or award from the company	+511	$48.91	$25K	3,771 direct	Filing · EDGAR
Apr 27, 2004	Grant or award from the company common stock	+511	$48.91	$25K	40,511 direct	Filing · EDGAR

Tercica Director · filings 2004 to 2008

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 16, 2008	Returned to the company	−3,333	$9.00	$30K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−22,500	$8.85	$199K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$8.25	$93K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$4.60	$52K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−11,250	$6.60	$74K	0 direct	Filing · EDGAR
Oct 16, 2008	Returned to the company Non-Qualified Stock Option (right to buy)	−13,334	$4.19	$56K	0 direct	Filing · EDGAR
May 20, 2008	Grant or award from the company	+3,333			3,333 direct	Filing · EDGAR
May 20, 2008	Grant or award from the company Non-Qualified Stock Option (right to buy)	+13,334			13,334 direct	Filing · EDGAR
May 24, 2007	Grant or award from the company Non-Qualified Stock Options (right to buy)	+11,250			11,250 direct	Filing · EDGAR
Jun 6, 2006	Grant or award from the company Non-Qualified Stock Options (right to buy)	+11,250			11,250 direct	Filing · EDGAR
Jun 1, 2005	Grant or award from the company Non-Qualified Stock Options (right to buy)	+11,250			11,250 direct	Filing · EDGAR
Oct 13, 2004	Grant or award from the company Non-Qualified Stock Option (right to buy)	+22,500			22,500 direct	Filing · EDGAR

All 115 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Aug 20, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 18, 2026	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
Jun 18, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 16, 2026	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
May 26, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 17, 2026	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 12, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 20, 2025	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 16, 2025	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
May 21, 2024	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 12, 2024	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 31, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 16, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 15, 2023	Form 144/A	Corcept Therapeutics CORT	Filing · EDGAR
Aug 14, 2023	Form 144	Corcept Therapeutics CORT	Filing · EDGAR
May 23, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 9, 2023	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 14, 2023	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Jun 2, 2022	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 31, 2022	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 18, 2022	Form 4/A	Corcept Therapeutics CORT	Filing · EDGAR
Nov 24, 2021	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Jun 4, 2021	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
May 28, 2021	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 13, 2021	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 16, 2021	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Jun 5, 2020	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
May 29, 2020	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 27, 2020	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 18, 2019	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Sep 13, 2019	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Jun 20, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 6, 2019	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Jun 4, 2019	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 17, 2019	Form 4/A	Symantec	Filing · EDGAR
May 15, 2019	Form 4	Symantec	Filing · EDGAR
Aug 22, 2018	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 7, 2018	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
May 21, 2018	Form 4	Symantec	Filing · EDGAR
Nov 30, 2017	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Nov 17, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 20, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 20, 2017	Form 4/A	Corcept Therapeutics CORT	Filing · EDGAR
Jul 14, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 2, 2017	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
May 26, 2017	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 16, 2017	Form 4	Symantec	Filing · EDGAR
Feb 14, 2017	Form 5	Corcept Therapeutics CORT	Filing · EDGAR
Nov 14, 2016	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 22, 2016	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 7, 2016	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
May 19, 2016	Form 4	Symantec	Filing · EDGAR
Jul 9, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 22, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 20, 2015	Form 4	Symantec	Filing · EDGAR
May 18, 2015	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Mar 30, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 24, 2015	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 17, 2014	Form 4	Symantec	Filing · EDGAR
May 15, 2014	Form 4	Symantec	Filing · EDGAR
May 12, 2014	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 15, 2014	Form 4	Adamas Pharmaceuticals	Filing · EDGAR
Apr 9, 2014	Form 3	Adamas Pharmaceuticals	Filing · EDGAR
May 20, 2013	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 14, 2013	Form 4	Symantec	Filing · EDGAR
Nov 6, 2012	Form 4	Symantec	Filing · EDGAR
Jun 15, 2012	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 9, 2012	Form 4	Symantec	Filing · EDGAR
Apr 2, 2012	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 7, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 23, 2011	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 17, 2011	Form 4	Symantec	Filing · EDGAR
Jul 12, 2010	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 12, 2010	Form 4	Symantec	Filing · EDGAR
Apr 23, 2010	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 20, 2009	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jun 15, 2009	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 13, 2009	Form 4	Symantec	Filing · EDGAR
Feb 10, 2009	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Nov 13, 2008	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 20, 2008	Form 4	Tercica	Filing · EDGAR
Jun 11, 2008	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 21, 2008	Form 4	Tercica	Filing · EDGAR
May 1, 2008	Form 4	Symantec	Filing · EDGAR
Mar 27, 2008	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 21, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Aug 20, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
May 24, 2007	Form 4	Tercica	Filing · EDGAR
May 3, 2007	Form 4	Symantec	Filing · EDGAR
Apr 3, 2007	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Dec 18, 2006	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 18, 2006	Form 4	Symantec	Filing · EDGAR
Jun 19, 2006	Form 4	Tercica	Filing · EDGAR
Apr 27, 2006	Form 4	Symantec	Filing · EDGAR
Mar 6, 2006	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Mar 3, 2006	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Feb 22, 2006	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Sep 21, 2005	Form 4	Symantec	Filing · EDGAR
Aug 29, 2005	Form 4	Symantec	Filing · EDGAR
Jun 3, 2005	Form 4	Tercica	Filing · EDGAR
Jun 1, 2005	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Apr 27, 2005	Form 4	Symantec	Filing · EDGAR
Nov 10, 2004	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Oct 20, 2004	Form 4	Tercica	Filing · EDGAR
Oct 20, 2004	Form 3	Tercica	Filing · EDGAR
Sep 17, 2004	Form 4	Symantec	Filing · EDGAR
Jul 27, 2004	Form 4	Corcept Therapeutics CORT	Filing · EDGAR
Jul 27, 2004	Form 3/A	Corcept Therapeutics CORT	Filing · EDGAR
Jul 22, 2004	Form 3	Corcept Therapeutics CORT	Filing · EDGAR
Jun 29, 2004	Form 4/A	Symantec	Filing · EDGAR
Apr 28, 2004	Form 4	Symantec	Filing · EDGAR
Nov 25, 2003	Form 4	Symantec	Filing · EDGAR
May 13, 2003	Form 4	Symantec	Filing · EDGAR
Apr 8, 2003	Form 3	Paper or text filing, not machine-readable	EDGAR
Apr 8, 2003	Form 4	Paper or text filing, not machine-readable	EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 1:28 AM ET. The filing on SEC.gov is the record.